SAN ANTONIO, November 05, 2025--bioAffinity Technologies announced the volume of CyPath® Lung tests processed in October ...
Staged LVRS offered similar hospital length of stay and complication rates as bilateral LVRS. Both approaches led to clinically significant improvements in pulmonary function. Notably, the staged ...
TipRanks on MSN
bioAffinity Technologies Reports Surge in CyPath® Lung Tests
Affinity Technologies, Inc. ( ($BIAF) ) just unveiled an announcement. On November 5, 2025, bioAffinity Technologies announced significant ...
bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW),a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, today announced sales of its CyPath® Lung ...
Leesburg, VA, November 2, 2022—According to an accepted manuscript published in ARRS’ American Journal of Roentgenology (AJR), metrics derived from dual-energy CT (DECT) can provide insight on ...
BARCELONA, Spain — For patients with emphysema who are suitable candidates for lung volume reduction surgery, there were no differences at 1 year in either lung function, dyspnea, or exercise capacity ...
We’ve all felt winded when taking the stairs or dealt with a cough from time to time. But if these issues linger, they could be early signs of chronic obstructive pulmonary disease (COPD). If you have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback